TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,092,565
|
2,517,996
|
2,185,033 |
| Earnings before taxes |
316,034
|
768,469
|
734,058 |
| Total assets |
3,623,676
|
3,439,426
|
3,140,663 |
| Current assets |
1,198,723
|
1,451,488
|
2,112,445 |
| Current liabilities |
2,180,601
|
1,939,308
|
1,882,633 |
| Equity capital |
307,426
|
661,277
|
633,585 |
| - share capital |
42,853
|
42,853
|
42,853 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
8.5%
|
19.2%
|
20.2% |
| Turnover per employee |
5,979
|
7,194
|
6,243 |
| Profit as a percentage of turnover |
15.1%
|
30.5%
|
33.6% |
| Return on assets (ROA) | |||
| Current ratio |
55.0%
|
74.8%
|
112.2% |
| Return on equity (ROE) |
102.8%
|
116.2%
|
115.9% |
| Change turnover |
-425,431
|
332,963
|
729,962 |
| Change turnover % |
-17%
|
15%
|
50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.